Trial Profile
Symbicort Turbuhaler 30/60 Specific Clinical Experience Investigation for Long-term Use.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 09 May 2019
Price :
$35
*
At a glance
- Drugs Budesonide/formoterol (Primary)
- Indications Asthma
- Focus Adverse reactions
- Acronyms ENSURE
- Sponsors AstraZeneca
- 01 May 2013 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 04 Feb 2013 Planned end date changed from 1 Jun 2012 to 1 Apr 2013 as reported by ClinicalTrials.gov.
- 17 Jan 2012 Actual patient number (1500) added as reported by ClinicalTrials.gov.